CRISPR Therapeutics – CRSP: Short Squeeze bei der Schweizer Biotech-Aktie?
Short Float bei 29.37% Seit Jahren keine Gewinne bei CRISPR Therapeutics (CRSP). Insider kauft trotzdem! JETZT Pullback-Setup! CRISPR Therapeutics (CRSP) ...
Saturday, August 1, 2026
Tag: CRISPR
Copenhagen’s SNIPR Biome gets €35M injection to advance CRISPR therapies for antimicrobial resistance
Copenhagen-based SNIPR Biome, a biotech company focused on developing precision medicines through CRISPR technology for microbial gene therapy, has successfully ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.